Overview
Veterinary contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) offer a unique service model that aids animal health organizations in the development, testing, and ultimately manufacture of veterinary medicines, vaccines, and biologics among others. CROs are responsible for research elements, e.g., preclinical studies, safety studies, clinical trials and ensuring regulatory compliance; while a CDMO supports the formulation, process and product development, scale-up, and GMP manufacturing. Veterinary CROs and CDMOs support animal health companies in overcoming issues pertaining to expertise, infrastructure, and cost showing an overall benefit through shortened time to market and allowing animal health companies to focus on their core strategic goals.

To learn more about this report, download the PDF brochure
Rapid growth in companion-animal healthcare spending to drive market growth
The veterinary CRO and CDMO market is heavily influenced by the surge in companion-animal healthcare spending because pet owners are increasingly looking for more advanced therapies (biologics, oncology and specialty medicines). In the US alone, total expenditure on pets (i.e., pet industry) increased substantially by c.46% between 2020-2024e. Expenditure on pet health & products increased c.25% between 2020-2024e (Source: APPA). As disposable incomes rise, and emotional bonds between pets and their owners strengthen, consumers are more willing to spend money for the absolute best care for their companion animals. This requires animal health companies to build pipelines and to leverage outsourcing services (to CROs and CDMOs) for preclinical studies, research and development, clinical testing for new molecular entities, and manufacturing. All this bodes well for faster times to market, increased services needed, and continued growth in the market at a global level.

To learn more about this report, download the PDF brochure
Growing consolidation & preference for platform service to boost market growth
Increasing consolidation & preference for platform services is driving growth in the veterinary CRO and CDMO markets by offering integrated, end-to-end solutions that more effectively facilitate the development and manufacture of products. Instead of working with multiple organizations with distinct services, animal health clients increasingly prefer to partner with service providers that can offer everything from discovery and toxicology to clinical trials and regulatory and commercial-scale production under one umbrella. This reduces the complexity of managing various timelines, expands potential efficiencies, and improves cost effectiveness. Consolidation through M&A also expands global reach and capabilities, enabling service providers to offer comprehensive platforms that attract more clients and drive sustained market expansion.
Competitive Landscape Analysis
The global veterinary CRO and CDMO market is marked by the presence of established and emerging market players such as Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab; among others. Some of the key strategies adopted by market players include new service launch, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 9% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | By Product, Animal Type, Therapeutic Area, Phase, End User |
| Regional Scope |
|
| Key Companies Mapped | Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Veterinary CRO and CDMO Market Segmentation
This report by Medi-Tech Insights provides thesize of the global veterinary CRO and CDMO market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, animal type, therapeutic area, phase, and end user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Small Molecules
- Biologics
- Nutraceuticals and Feed Additives
- Medical Devices
Market Size & Forecast (2023-2030), By Animal Type, USD Million
- Companion Animals
- Livestock Animals
Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
- Infectious Diseases
- Oncology
- Dermatology
- Pain & Inflammation Management Disorders
- Others
Market Size & Forecast (2023-2030), By Phase, USD Million
- Pre-clinical
- Clinical
- Commercial
Market Size & Forecast (2023-2030), By End User, USD Million
- Veterinary Pharmaceutical and Biopharmaceutical Companies
- Veterinary Medical Device Companies
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the veterinary CRO and CDMO market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the veterinary CRO and CDMO market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Related Reports
- Veterinary Ultrasound Market Global Industry Analysis, Size, Share, Growth & Revenue for Forecast 2024 to 2029
- "https://meditechinsights.com/veterinary-imaging-market/">Global Veterinary Imaging Market Size & Trends Report Segmented by Product (X-ray, Ultrasound), Solutions (Equipment, Accessories /Consumables, PACS), Animal Type (Large, Small), Application (Orthopedic, Oncology, Cardiology), & Regional Forecast to 2030
- Global Veterinary Diagnostics Market Size & Trends Report Segmented by Product (Consumables, Instruments), Test Type (Clinical Chemistry, Microbiology, Others), Animal Type (Production, Companion), End-user (Veterinary Hospitals & Clinics) Analysis & Regional Forecasts to 2030
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.